These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 30166499)

  • 1. A causal link between oxidative stress and inflammation in cardiovascular and renal complications of diabetes.
    Jha JC; Ho F; Dan C; Jandeleit-Dahm K
    Clin Sci (Lond); 2018 Aug; 132(16):1811-1836. PubMed ID: 30166499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial or vascular smooth muscle cell-specific expression of human NOX5 exacerbates renal inflammation, fibrosis and albuminuria in the Akita mouse.
    Jha JC; Dai A; Holterman CE; Cooper ME; Touyz RM; Kennedy CR; Jandeleit-Dahm KAM
    Diabetologia; 2019 Sep; 62(9):1712-1726. PubMed ID: 31222503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the renin-angiotensin-aldosterone-system on cardiovascular and renal complications in diabetes mellitus.
    Hayashi T; Takai S; Yamashita C
    Curr Vasc Pharmacol; 2010 Mar; 8(2):189-97. PubMed ID: 19485896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular disease in type 1 diabetes: A review of epidemiological data and underlying mechanisms.
    Vergès B
    Diabetes Metab; 2020 Nov; 46(6):442-449. PubMed ID: 32998054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linking RAGE and Nox in diabetic micro- and macrovascular complications.
    Koulis C; Watson AMD; Gray SP; Jandeleit-Dahm KA
    Diabetes Metab; 2015 Sep; 41(4):272-281. PubMed ID: 26323666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation, oxidative stress, apoptosis, and autophagy in diabetes mellitus and diabetic kidney disease: the Four Horsemen of the Apocalypse.
    Turkmen K
    Int Urol Nephrol; 2017 May; 49(5):837-844. PubMed ID: 28035619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress and diabetic cardiovascular disorders: roles of mitochondria and NADPH oxidase.
    Shen GX
    Can J Physiol Pharmacol; 2010 Mar; 88(3):241-8. PubMed ID: 20393589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOCS1-targeted therapy ameliorates renal and vascular oxidative stress in diabetes via STAT1 and PI3K inhibition.
    Lopez-Sanz L; Bernal S; Recio C; Lazaro I; Oguiza A; Melgar A; Jimenez-Castilla L; Egido J; Gomez-Guerrero C
    Lab Invest; 2018 Oct; 98(10):1276-1290. PubMed ID: 29540859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases.
    Fiorentino TV; Prioletta A; Zuo P; Folli F
    Curr Pharm Des; 2013; 19(32):5695-703. PubMed ID: 23448484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial dysfunction, oxidative stress and diabetic cardiovascular disorders.
    Shen GX
    Cardiovasc Hematol Disord Drug Targets; 2012 Dec; 12(2):106-12. PubMed ID: 23030449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of advanced glycation end products in diabetes-associated cardiovascular and renal disease.
    Cooper ME
    Am J Hypertens; 2004 Dec; 17(12 Pt 2):31S-38S. PubMed ID: 15607433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a "glycoxidation-centric" point of view.
    Chilelli NC; Burlina S; Lapolla A
    Nutr Metab Cardiovasc Dis; 2013 Oct; 23(10):913-9. PubMed ID: 23786818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy.
    Elmarakby AA; Sullivan JC
    Cardiovasc Ther; 2012 Feb; 30(1):49-59. PubMed ID: 20718759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxygen radicals in cardiovascular-renal disease.
    Schnackenberg CG
    Curr Opin Pharmacol; 2002 Apr; 2(2):121-5. PubMed ID: 11950621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Mitochondria and Reactive Oxygen Species-Driven Pathogenesis in Diabetic Nephropathy.
    Lindblom R; Higgins G; Coughlan M; de Haan JB
    Rev Diabet Stud; 2015; 12(1-2):134-56. PubMed ID: 26676666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of free radicals, oxidative stress and antioxidant systems in diabetic vascular disease.
    Jakus V
    Bratisl Lek Listy; 2000; 101(10):541-51. PubMed ID: 11218944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrion and its role in diabetic nephropathy.
    Khoshjou F; Dadras F
    Iran J Kidney Dis; 2014 Sep; 8(5):355-8. PubMed ID: 25194400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of oxidative stress in diabetic vascular and neural disease.
    Yorek MA
    Free Radic Res; 2003 May; 37(5):471-80. PubMed ID: 12797466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are reactive oxygen species still the basis for diabetic complications?
    Di Marco E; Jha JC; Sharma A; Wilkinson-Berka JL; Jandeleit-Dahm KA; de Haan JB
    Clin Sci (Lond); 2015 Jul; 129(2):199-216. PubMed ID: 25927680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Oxidative Stress and Inflammatory Factors in Diabetic Kidney Disease.
    Aghadavod E; Khodadadi S; Baradaran A; Nasri P; Bahmani M; Rafieian-Kopaei M
    Iran J Kidney Dis; 2016 Nov; 10(6):337-343. PubMed ID: 27903991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.